Results 201 to 210 of about 1,325,240 (268)
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
What Is Known About Persons with Intellectual Disabilities and Cardiovascular Risk Factors-A Scoping Review. [PDF]
Rein L +6 more
europepmc +1 more source
L‐cysteine‐configured chiral polyurethane nanoparticles suppress ocular inflammation and reduce extracellular matrix (ECM) degradation in ectopia lentis by regulating macrophages polarization and inhibiting nuclear factor kappa B signaling pathway. By promoting zonular fiber‐associated protein restoration and tissue repair, this minimally invasive ...
Yinuo Wen +17 more
wiley +1 more source
Cardiovascular risk profiles in patients with primary sclerosing cholangitis. [PDF]
Sleutjes JAM +6 more
europepmc +1 more source
Cigarette smoke accelerates the aging of immune cells in the lung. By combining human single‐cell sequencing, cell culture, and mouse models, the authors show that the protein GEM drives mitochondrial damage and senescence in alveolar macrophages by suppressing SIRT3.
Jin Wang +8 more
wiley +1 more source
Isometric Handgrip Training and Cardiovascular Risk Modulation: State of the Art. [PDF]
Geraci C +6 more
europepmc +1 more source
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong +24 more
wiley +1 more source
Impact of Y loss in blood on male atherosclerosis and cardiovascular risk
Forsberg L +12 more
europepmc +1 more source
Correction: Trends in cardiovascular risk factors in poland: results from the comprehensive cardiovascular risk prevention program. [PDF]
Kubielas G +8 more
europepmc +1 more source
Cardiovascular Risk in Pancreatic Cancer: A Meta-Analysis of 197 Studies. [PDF]
Németh J +12 more
europepmc +1 more source

